TCL Archive Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival July 27, 2012
TCL Archive Scripps, Sandoz Deal Becomes Case Study As NI Rethinks Sponsored Research January 28, 1994
